TC
TMO icon

Truvestments Capital’s Thermo Fisher Scientific TMO Stock Holding History

Truvestments Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33
Closed -$16.2K – 1286
2026
Q1 		$16.2K Hold
33
– – ﹤0.01% 681
2025
Q4 		$19.1K Hold
33
– – ﹤0.01% 601
2025
Q3 		$16K Buy
33
+24
+267% +$11.2K ﹤0.01% 637
2025
Q2 		$3.65K Sell
9
-20
-69% -$8.36K ﹤0.01% 775
2025
Q1 		$14.4K Buy
29
+19
+190% +$10.3K ﹤0.01% 599
2024
Q4 		$5.2K Hold
10
– – ﹤0.01% 695
2024
Q3 		$6.19K Buy
+10
New +$5.92K ﹤0.01% 652
2024
Q2 		– Sell
-10
Closed -$5.81K – 647
2024
Q1 		$5.81K Hold
10
– – ﹤0.01% 543
2023
Q4 		$5.31K Sell
10
-24
-71% -$11.6K ﹤0.01% 592
2023
Q3 		$17.2K Buy
34
+25
+278% +$13.3K 0.01% 394
2023
Q2 		$4.7K Hold
9
– – ﹤0.01% 533
2023
Q1 		$5.19K Buy
+9
New +$5.07K ﹤0.01% 508
2020
Q3 		– Sell
-5
Closed -$1K – 532
2020
Q2 		$1K Buy
+5
New +$1.68K ﹤0.01% 551
2019
Q2 		– Sell
-105
Closed -$29K – 778
2019
Q1 		$29K Buy
+105
New +$26.1K 0.02% 346
2018
Q3 		$86K Buy
+350
New +$80.5K 0.04% 279

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Truvestments Capital's TMO Position: Q2 2026 in Review

Truvestments Capital sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 33 shares — an estimated $16.2K sold.

Truvestments Capital first reported a position in TMO in Q3 2018 and held it in 15 quarters. The position peaked at $86K in Q3 2018. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Truvestments Capital reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Truvestments Capital sold 33 Thermo Fisher Scientific shares in Q2 2026, an estimated $16.2K.
  • Truvestments Capital first reported a position in Thermo Fisher Scientific in Q3 2018 and held it in 15 quarters.
  • Truvestments Capital's Thermo Fisher Scientific position peaked at $86K in Q3 2018.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.